- Home
- PKBK vs IMRX Comparison
PKBK vs IMRX Comparison
Compare PKBK & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKBK
- IMRX
- Stock Information
- Founded
- PKBK 1999
- IMRX 2008
- Country
- PKBK United States
- IMRX United States
- Employees
- PKBK N/A
- IMRX N/A
- Industry
- PKBK Major Banks
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- PKBK Finance
- IMRX Health Care
- Exchange
- PKBK Nasdaq
- IMRX Nasdaq
- Market Cap
- PKBK 269.2M
- IMRX 232.9M
- IPO Year
- PKBK N/A
- IMRX 2021
- Fundamental
- Price
- PKBK $22.22
- IMRX $8.31
- Analyst Decision
- PKBK
- IMRX Strong Buy
- Analyst Count
- PKBK 0
- IMRX 4
- Target Price
- PKBK N/A
- IMRX $13.75
- AVG Volume (30 Days)
- PKBK 35.6K
- IMRX 1.2M
- Earning Date
- PKBK 10-17-2025
- IMRX 11-12-2025
- Dividend Yield
- PKBK 3.23%
- IMRX N/A
- EPS Growth
- PKBK 42.58
- IMRX N/A
- EPS
- PKBK 2.56
- IMRX N/A
- Revenue
- PKBK $66,879,999.00
- IMRX N/A
- Revenue This Year
- PKBK N/A
- IMRX N/A
- Revenue Next Year
- PKBK N/A
- IMRX N/A
- P/E Ratio
- PKBK $8.69
- IMRX N/A
- Revenue Growth
- PKBK 3.52
- IMRX N/A
- 52 Week Low
- PKBK $16.94
- IMRX $1.10
- 52 Week High
- PKBK $24.29
- IMRX $9.37
- Technical
- Relative Strength Index (RSI)
- PKBK 52.66
- IMRX 73.13
- Support Level
- PKBK $22.11
- IMRX $7.82
- Resistance Level
- PKBK $22.85
- IMRX $8.85
- Average True Range (ATR)
- PKBK 0.33
- IMRX 0.78
- MACD
- PKBK -0.06
- IMRX 0.24
- Stochastic Oscillator
- PKBK 23.66
- IMRX 75.46
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.